The Senate on Friday was informed that the country had the lowest research on medicine and drugs whereas the countries in the region were extensively investing in cutting-edge research on developing drugs from local salts and bringing innovation in pharmaceutical products.
Senator Anousha Rehman in her supplementary query on Drug Regulatory Authority (DRAP)'s Central Research Fund (CRF) allocations and expenditure. She also sought a response on DRAP's inquiry and investigation procedures' double-checking mechanisms.
COMMENTS
Comments are moderated and generally will be posted if they are on-topic and not abusive.
For more information, please see our Comments FAQ